Biopharma innovation centre coming to UQ
05 July, 2016A $10 million biopharmaceutical centre will be established at The University of Queensland to train the next generation of scientists and enhance Australia's capabilities in the pharmaceutical sector.
New asthma treatment being trialled at UQ
29 June, 2016Researchers at UQ's School of Biomedical Sciences are testing a new drug that has the potential to reverse or slow the development of asthma, as opposed to current drugs which just ease the symptoms of the disease.
Better late than never — Golden Goose Award goes to 'sex life of the screwworm' researchers
29 June, 2016Edward F Knipling and Raymond C Bushland, who were ridiculed for their study of the sex life of the screwworm fly during the mid-20th century, will be posthumously honoured later this year with a Golden Goose Award.
Mass spectrometry for pharma and biotech
23 June, 2016OMass Technologies has used native mass spectrometry to conquer the challenge of deciphering the interactions of membrane proteins.
Johnson & Johnson encourages innovation in Queensland
23 June, 2016The Johnson & Johnson Innovation Partnering Office @ QUT aims to improve access to global health and medical innovation in Queensland and beyond.
Stem cell company prepares for Phase 1 clinical trial
22 June, 2016Cynata Therapeutics intends to file an application for regulatory approval with the MHRA for a Phase 1 clinical trial of CYP-001, the company's lead Cymerus mesenchymal stem cell (MSC) product.
Improved drug delivery inside cells
15 June, 2016Drug delivery company Phylogica has announced the improved delivery of antisense oligonucleotide drugs inside cells.
Hayfever trial to commence this month
09 June, 2016Paradigm Biopharma has announced a series of updates surrounding its clinical trial program for hayfever, which will, for the first time, see pentosan polysulfate sodium (PPS) delivered intranasally in human volunteers.
New GHIT Fund partnerships enable R&D investment
07 June, 2016The Global Health Innovative Technology Fund (GHIT Fund) has announced funding partnerships with 10 new organisations, including major global pharmaceutical and biotechnology companies.
Biotech CEOs are optimistic about 2016
01 June, 2016According to the 2016 Biotechnology Industry Position Survey of industry CEOs, biotechnology is front and centre of Australia's post-mining boom economic transition.
QBiotics presents its veterinary cancer compound
01 June, 2016QBiotics has outlined the latest clinical developments in cancer compound EBC-46 to an audience of veterinary cancer experts.
CSL celebrates dual FDA approvals
31 May, 2016CSL has received US FDA approval for two of the biotherapeutics company's products.
Peptides offer prospects for Alzheimer's treatment
30 May, 2016Biotech company Alzhyme has licensed a range of peptides, developed at the University of Tasmania, which have the potential to treat Alzheimer's disease.
AusCann and Murdoch Uni sign medical cannabis research alliance
25 May, 2016AusCann has announced a five-year research alliance with Murdoch University, intended to lead to the development of projects in the field of medicinal cannabis.
Biotron boasts anti-Zika drug compounds
23 May, 2016Shares in Biotron jumped 25% as the company announced that two compounds from its library have shown positive activity against Zika virus.
